Clinical trial
A Prospective Study Comparing Total Intravenous Anesthesia With Propofol and Remifentanil vs. Propofol and Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion and Instrumentation
NCT06096181 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study Comparing Total Intravenous Anesthesia With Propofol and Remifentanil vs. Propofol and Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion and Instrumentation
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 20, 2023
- Completion date
- December 24, 2024
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adolescent idiopathic scoliosis, dexmedetomidine, multimodal analgesia, opioid induced hyperalgesia, posterior spinal fusion, remifentanil